HomeRLYB • NASDAQ
add
Rallybio Corp
Previous close
$1.08
Day range
$1.08 - $1.10
Year range
$0.95 - $3.46
Market cap
42.51M USD
Avg Volume
77.27K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 299.00K | — |
Operating expense | 4.12M | -32.10% |
Net income | -11.47M | 37.60% |
Net profit margin | -3.83K | — |
Earnings per share | -0.26 | 42.22% |
EBITDA | -12.03M | 37.73% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 75.14M | -38.10% |
Total assets | 79.01M | -40.68% |
Total liabilities | 8.19M | -14.81% |
Total equity | 70.82M | — |
Shares outstanding | 41.49M | — |
Price to book | 0.63 | — |
Return on assets | -35.19% | — |
Return on capital | -39.86% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -11.47M | 37.60% |
Cash from operations | -13.54M | 17.76% |
Cash from investing | 22.20M | 623.29% |
Cash from financing | -11.00K | — |
Net change in cash | 8.65M | 164.54% |
Free cash flow | -9.73M | 3.96% |
About
Founded
2018
Headquarters
Website
Employees
25
